Literature DB >> 29800813

Postnatal high-fat diet sex-specifically exacerbates prenatal dexamethasone-induced hypertension: Mass spectrometry-based quantitative proteomic approach.

Chien-Ning Hsu1, Wan-Tz Lai2, Yu-Ju Lin3, You-Lin Tain4.   

Abstract

Hypertension can originate from pre- and post-natal insults. High-fat (HF) diet and prenatal dexamethasone (DEX) exposure are both involved in hypertension of developmental origins. We examined whether postnatal HF diet sex-specifically increases the vulnerability to prenatal DEX exposure-induced programmed hypertension in adult offspring. Additionally, we sought to identify candidate proteins involved in programmed hypertension through a mass spectrometry-based quantitative proteomic approach. Male and female offspring were studied separately: control, DEX, HF, and DEX + HF (n=8/group). Pregnant Sprague-Dawley rats received dexamethasone (0.1 mg/kg body weight) or vesicle from gestational day 16-22. Offspring received high-fat diet (D12331, Research Diets) or regular diet from weaning to 4 months of age. Rats were sacrificed at 4 months of age. We found that postnatal HF diet increased vulnerability of prenatal DEX-induced hypertension in male but not in female adult offspring. Additionally, HF and DEX elicited renal programming in a sex-specific fashion. In males, DEX + HF increased renal parvalbumin (PVALB) and carbonic anhydrase III (CA III) protein levels. While prenatal DEX down-regulated PVALB and CA III protein abundance in female offspring kidneys. Moreover, DEX + HF increased renal protein level of type 3 sodium hydrogen exchanger (NHE3) in males but not in females. In conclusion, postnatal HF diet and prenatal DEX exposure synergistically induced programmed hypertension in male-only offspring. DEX + HF induced sex-specific alterations of protein profiles in offspring kidneys. By identifying candidate proteins underlying sex-specific mechanisms, our results could lead to novel offspring sex-specific interventions to prevent hypertension induced by antenatal corticosteroids and postnatal HF intake in both sexes.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucocorticoid; Hypertension; Proteomics; Sex differences; Sodium transporter

Mesh:

Substances:

Year:  2018        PMID: 29800813     DOI: 10.1016/j.jnutbio.2018.04.006

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  5 in total

1.  Gender differences in the renal changes induced by a prolonged high-fat diet in rats with altered renal development.

Authors:  Juan M Moreno; Carlos M Martinez; Carlos de Jodar; Virginia Reverte; Antonio Bernabé; F Javier Salazar; María T Llinás
Journal:  J Physiol Biochem       Date:  2021-04-14       Impact factor: 4.158

Review 2.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

3.  Loss of the Protective Effect of Estrogen Contributes to Maternal Gestational Hypertension-Induced Hypertensive Response Sensitization Elicited by Postweaning High-Fat Diet in Female Offspring.

Authors:  Baojian Xue; Yang Yu; Terry G Beltz; Fang Guo; Shun-Guang Wei; Alan Kim Johnson
Journal:  J Am Heart Assoc       Date:  2022-01-11       Impact factor: 6.106

4.  Anomalous AMPK-regulated angiotensin AT1R expression and SIRT1-mediated mitochondrial biogenesis at RVLM in hypertension programming of offspring to maternal high fructose exposure.

Authors:  Yung-Mei Chao; Kay L H Wu; Pei-Chia Tsai; You-Lin Tain; Steve Leu; Wei-Chia Lee; Julie Y H Chan
Journal:  J Biomed Sci       Date:  2020-05-23       Impact factor: 8.410

Review 5.  Maternal High-Fat Diet and Offspring Hypertension.

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2022-07-25       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.